Search

Ocugen Inc

Cerrado

1.22 -3.17

Resumen

Variación precio

24h

Actual

Mínimo

1.23

Máximo

1.29

Métricas clave

By Trading Economics

Ingresos

-1.5M

-19M

Ventas

1.7M

1.5M

BPA

-0.06

Margen de beneficios

-1,250.946

Empleados

116

EBITDA

-987K

-17M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+661.42% upside

Dividendos

By Acuity

Próximas Ganancias

31 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-176M

450M

Apertura anterior

4.39

Cierre anterior

1.22

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 jul 2026, 23:52 UTC

Mexico's Q2 2026 GDP Growth Rate Release on July 30 Amid Cautious Economic Outlook and Market Volatility.

23 jul 2026, 23:52 UTC

Germany's Inflation Rate Release on July 30, 2026 Sparks Market Speculation Amid Cooling Prices and Geopolitical Tensions.

23 jul 2026, 23:52 UTC

Germany's July Inflation Rate Release Sparks Caution Among Investors Amid Rising Oil Prices and Geopolitical Tensions.

23 jul 2026, 23:52 UTC

Japan's June inflation rises to 1.7%, but remains below Bank of Japan’s target, raising concerns over wage growth and global supply chain issues.

23 jul 2026, 23:52 UTC

UK Consumer Confidence Index Improves to -17.0, Exceeding Expectations Amid Positive Market Sentiment and Geopolitical Concerns

23 jul 2026, 23:52 UTC

Australia's S&P Global Manufacturing PMI rises to 51.7 in July, signaling continued growth amid inflationary pressures and increased hiring activity.

23 jul 2026, 23:52 UTC

Australia's S&P Global Services PMI rises to 53.0 in July, signaling growth and boosting economic optimism despite global inflation concerns.

23 jul 2026, 23:52 UTC

New Home Sales Expected at 610,000 Units Amid Rising Mortgage Rates and Declining Buyer Sentiment

23 jul 2026, 23:52 UTC

Cautious Market Sentiment Ahead of U.S. New Home Sales Report Amid Rising Mortgage Rates and Declining Buyer Activity

23 jul 2026, 23:52 UTC

Japan's Retail Sales Expected to Continue Growth Amid Strong Trade Data, but Inflation Concerns Loom Ahead of July 30 Release.

23 jul 2026, 23:52 UTC

Japan's Industrial Production Faces Caution Ahead of July Release Amid Mixed Economic Signals and Rising Inflation.

23 jul 2026, 23:52 UTC

The Nikkei 225 Index is trading lower in after-market hours, continuing its decline since Thursday. No specific news was identified to explain this move.

23 jul 2026, 23:51 UTC

News

Cavco Industries Inc. announced its first-quarter earnings release date, contributing to positive investor sentiment. Shares are higher in after-market trading.

23 jul 2026, 23:51 UTC

Woodward Inc. shares are lower in after-market trading, showing notable volatility with fluctuations between a high of 1.07% and a low of -1.01%.

23 jul 2026, 23:51 UTC

Antero Resources Corp shares are higher in after-market trading, supported by rising crude oil prices amid inflation and interest rate concerns.

23 jul 2026, 23:51 UTC

NewMarket Corp shares are lower in after-market hours, despite earlier gains. The stock is below its 20-day moving average amid inflation concerns.

23 jul 2026, 23:51 UTC

Correlated Moves

Coeur Mining Inc shares are higher in after-market trading, aligning with a positive trend among gold-related equities amid broader market resilience despite bond market instability.

23 jul 2026, 23:51 UTC

Xenon Pharmaceuticals Inc shares are lower in after-market hours, continuing a downward trend with no specific news identified to explain the decline.

23 jul 2026, 23:51 UTC

Under Armour Inc shares are lower in after-market trading, reflecting significant selling pressure despite broader market resilience amid inflation concerns and rising crude oil prices.

23 jul 2026, 23:51 UTC

Southern Co. shares declined after-market, following a volatile session amid broader market resilience and concerns over inflation and rising crude oil prices.

23 jul 2026, 23:51 UTC

News

Scholastic Corp shares fell in after-market trading following fourth-quarter results, where revenue of $476.1 million missed expectations and net income dropped to $9.4 million.

23 jul 2026, 23:51 UTC

Trustmark Corp shares are lower in after-market hours, remaining below their 20-day moving average amid broader market instability reflected in rising credit default swaps.

23 jul 2026, 23:51 UTC

News
Social Media

Leidos Holdings shares are lower in after-market trading amid concerns over long-term revenue growth, despite a backlog of $48.37 billion.

23 jul 2026, 23:51 UTC

RPM International Inc shares are lower in after-market hours, reflecting notable weakness since Thursday's close and positioning below the 20-day moving average.

23 jul 2026, 23:51 UTC

Array Technologies Inc. shares declined after-market, continuing a downward trend since Thursday's close, despite an earlier session rebound from a cumulative low.

23 jul 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

23 jul 2026, 23:51 UTC

Tyson Foods Inc shares are lower in after-market trading, remaining near the lower end of their one-month range amid broader market instability.

23 jul 2026, 23:51 UTC

Spero Therapeutics Inc. shares are lower in after-market hours, continuing a downward trend after five consecutive sessions of declines.

23 jul 2026, 23:51 UTC

Fidelity National Information Services shares are higher in after-market trading, despite earlier session declines and a lack of specific news to explain the movement.

23 jul 2026, 23:51 UTC

American Water Works shares are higher in after-market trading, continuing positive momentum after three consecutive gains and positioning above the 20-day moving average.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

661.42% repunte

Estimación a 12 Meses

Media 9.67 USD  661.42%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat